Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Researchers have presented advances in the field of myocardial infarction, non-compaction cardiomyopathy and genetic aortic pathology, in addition to hosting a meeting between international experts on vascular aging.

Researchers at Vall d'Hebron have established a simple algorithm of recommendations for taking the arterial pulse, a rapid and non-invasive method for identifying patients with atrial fibrillation, a type of arrhythmia that increases the risk of stroke.

The knowledge of these mechanisms will help to develop pharmacological strategies to prevent heart failure associated with aging.

Les malalties minoritàries són greus, poc freqüents i afecten 5 de cada 10.000 persones. N'hi ha més de 7.000, un 80% de les quals són d'origen genètic. Generalment impliquen diversos òrgans i afecten les capacitats físiques, les habilitats mentals i les qualitats sensorials i de comportament de les persones afectades.

The objective of the Tartaglia project will be to train mathematical models to support decision making and contribute to personalized and precision medicine.

Today, 30 November, the main research lines in which both institutions will be working together are revealed.

The study shows that not only excess but also iron deficiency can have detrimental effects in acute myocardial ischemia.